Gliclazide SR 60mg & Dapagliflozin 10mg Tablets

GLICLAGLAZE DAPA 60-10 is a combination oral antidiabetic medication containing Gliclazide SR 60 mg and Dapagliflozin 10 mg, developed for the effective management of Type 2 Diabetes Mellitus in adults. This dual-action therapy helps achieve better blood glucose control when diet, exercise, and single-drug therapy are not sufficient. Gliclazide SR is a sulfonylurea that stimulates the pancreas to release insulin, while Dapagliflozin is an SGLT2 inhibitor that removes excess glucose through the urine by preventing its reabsorption in the kidneys. The sustained-release (SR) formulation of Gliclazide provides prolonged blood sugar control throughout the day. When combined with a healthy lifestyle, GLICLAGLAZE DAPA 60-10 helps improve glycemic control and reduces the risk of long-term diabetes-related complications.

Uses

GLICLAGLAZE DAPA 60-10 is commonly prescribed for:

• Management of Type 2 Diabetes Mellitus
• Improving blood glucose control alongside diet and exercise
• Lowering fasting and post-meal blood sugar levels
• Supporting long-term diabetes management
• Helping reduce the risk of diabetes-related complications through effective glycemic control

Benefits

GLICLAGLAZE DAPA 60-10 offers dual-action blood sugar control with complementary mechanisms.

• Effectively lowers fasting and postprandial blood glucose levels
• Stimulates insulin release from the pancreas
• Promotes elimination of excess glucose through urine
• Helps improve HbA1c levels
• Sustained-release formulation provides prolonged glucose control
• Supports healthy weight management when combined with lifestyle modifications
• May contribute to cardiovascular and kidney health benefits associated with SGLT2 inhibitor therapy in appropriate patients
• Helps reduce the risk of long-term diabetic complications affecting the eyes, kidneys, nerves, and heart

Dosage

Take GLICLAGLAZE DAPA 60-10 exactly as prescribed by your healthcare provider. The tablet is generally taken once daily with breakfast or the first main meal of the day. Swallow the sustained-release tablet whole with a glass of water without crushing, chewing, or breaking it. Follow your prescribed diabetic diet, maintain regular physical activity, and monitor your blood glucose levels as advised. Do not skip meals while taking this medicine, as doing so may increase the risk of hypoglycemia. Continue treatment regularly unless instructed otherwise by your physician.

Side Effects

Like all medicines, GLICLAGLAZE DAPA 60-10 may cause side effects, although not everyone experiences them.

Common side effects include:

• Low blood sugar (hypoglycemia)
• Frequent urination
• Increased thirst
• Urinary tract infection
• Genital fungal infections
• Dizziness
• Headache
• Nausea
• Mild stomach discomfort

Seek immediate medical attention if you experience severe hypoglycemia, allergic reactions, diabetic ketoacidosis, dehydration, or persistent unusual symptoms.

Precautions and Warnings

Before taking GLICLAGLAZE DAPA 60-10, inform your doctor if you have kidney disease, liver disease, heart failure, dehydration, recurrent urinary tract infections, or a history of severe hypoglycemia. Regular monitoring of blood glucose, HbA1c, and kidney function is recommended during treatment. Stay well hydrated, as Dapagliflozin increases urinary glucose excretion and may lead to dehydration. Limit alcohol consumption because it may increase the risk of hypoglycemia. Pregnant and breastfeeding women should use this medicine only if advised by their healthcare provider. Inform your physician about all prescription medicines, over-the-counter drugs, and herbal supplements to avoid possible drug interactions.

Conclusion

GLICLAGLAZE DAPA 60-10 (Gliclazide SR 60 mg & Dapagliflozin 10 mg Tablets) is an effective dual-combination therapy for adults with Type 2 Diabetes Mellitus requiring improved blood sugar control. By combining sustained insulin release with enhanced urinary glucose elimination, it helps achieve better glycemic control, improves HbA1c levels, and supports long-term diabetes management. When used as directed along with a balanced diet, regular exercise, and routine medical monitoring, GLICLAGLAZE DAPA 60-10 helps reduce the risk of diabetes-related complications and promotes better overall health and quality of life.